ATP1A3 gene mutations associated with infantile forms of schizophrenia
Scientists have identified novel genes associated with a specific form of schizophrenia the discovery will aid diagnosis and development of treatments...
List view / Grid view
Scientists have identified novel genes associated with a specific form of schizophrenia the discovery will aid diagnosis and development of treatments...
Scientists have identified the cell types underlying schizophrenia, the findings offer a roadmap for the development of new therapies to target the condition...
NIH scientists discover macromolecular complexes that could enable medication development...
Researchers at Osaka University have identified an immune cell that promotes the growth of neuron-supporting cells in the developing mouse brain.
Crystal structure of the dopamine 2 receptor bound to an antipsychotic drug provides a much-needed discovery in the quest to create effective drugs with fewer side effects...
Epilepsy drug reverses anti-social behaviours in mice with genes that produce variant proteins...
Researchers have presented a systematic catalogue of specific variable locations in the genome that influence gene activity in the human hippocampus...
A growing body of evidence suggests that virtual reality (VR) technology can be an effective part of treatment for phobias, posttraumatic stress disorder, and other mental health conditions, according to new research.
New research has identified sections of DNA associated with altered regulation of gene expression underlying schizophrenia.
Harvard University researchers have developed a multiregional brain-on-a-chip that models the connectivity between three distinct regions of the brain.
20 July 2016 | By Victoria White, Digital Content Producer
It had been suspected that the illness was an autoimmune disorder but now scientists have found strong evidence that schizophrenia is different...
7 June 2016 | By Victoria White, Digital Content Producer
The GFE3 protein may help researchers map the brain's connections and better understand how inhibitory synapses modulate brain function...
11 May 2016 | By Victoria White, Digital Content Producer
Boehringer Ingelheim will have the option of exclusive rights to a new compound for the treatment of schizophrenia to be discovered and developed at the LDC...